FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Susanna Furst

Research Profile

Living Beings

Chemicals & Drugs

Physiology

Drug Tolerance

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
E Lacko; B Noszal; R Rapavi; Pal Riba; J Timar; A Varadi; F Zador; Sándor Benyhe; A Borsodi; Susanna Furst; Sándor Hosztafi; Mahmoud Al-Khrasani
A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy.
Pal Riba; Tamas Friedmann; Kornél P Király; Mahmoud Al-Khrasani; Melinda Sobor; Muhammad F Asim; Mariana Spetea; Helmut Schmidhammer; Susanna Furst
Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
Mahmoud Al-Khrasani; Mariana Spetea; Tamas Friedmann; Pal Riba; Kornel Király; Helmut Schmidhammer; Susanna Furst
DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Susanna Furst (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: E Lacko; B Noszal; R Rapavi; Pal Riba; J Timar; A Varadi; F Zador; Sándor Benyhe; A Borsodi; Susanna Furst; Sándor Hosztafi; Mahmoud Al-Khrasani
A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy.
Current medicinal chemistry 2012;19(27):4699-707.
2010: Pal Riba; Tamas Friedmann; Kornél P Király; Mahmoud Al-Khrasani; Melinda Sobor; Muhammad F Asim; Mariana Spetea; Helmut Schmidhammer; Susanna Furst
Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
Brain research bulletin 2010;81(1):178-84.
2007: Mahmoud Al-Khrasani; Mariana Spetea; Tamas Friedmann; Pal Riba; Kornel Király; Helmut Schmidhammer; Susanna Furst
DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
Brain research bulletin 2007;74(5):369-75.
2006: K P Király; Pal Riba; Claudio D'Addario; Manuela Di Benedetto; Daniela Landuzzi; Sanzio Candeletti; Patrizia Romualdi; Susanna Furst
Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime.
Brain research bulletin 2006;70(3):233-9.
2005: László Köles; Susanna Furst; Peter Illes
P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses.
Drug news & perspectives 2005;18(2):85-101.
2003: Tibor Wenger; Gabriella Moldrich; Susanna Furst
Neuromorphological background of cannabis addiction.
Brain research bulletin 2003;61(2):125-8.
2002: Pal Riba; Yong Ben; Thi M-D Nguyen; Susanna Furst; Peter W Schiller; Nancy M Lee
[Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.
Current medicinal chemistry 2002;9(1):31-9.
2002: Pal Riba; Yong Ben; Andrew P Smith; Susanna Furst; Nancy M Lee
Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors.
The Journal of pharmacology and experimental therapeutics 2002;300(1):265-72.
2001: Pal Pacher; Zoltan Ungvari; Valéria Kecskeméti; Tamas Friedmann; Susanna Furst
Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle.
Canadian journal of physiology and pharmacology 2001;79(7):580-4.
2001: Pal Pacher; E Kohegyi; Valéria Kecskeméti; Susanna Furst
Current trends in the development of new antidepressants.
Current medicinal chemistry 2001;8(2):89-100.
2001: Katalin Müllner; Klára Gyires; Susanna Furst
Involvement of the opioid system in the central antisecretory action of alpha-2 adrenoceptor agonists in rat.
Journal of physiology, Paris 2001;95(1-6):209-14.
1999: Pal Pacher; Zoltan Ungvari; P P Nanasi; Susanna Furst; Valéria Kecskeméti
Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?
Current medicinal chemistry 1999;6(6):469-80.
1998: Pal Pacher; Zoltan Ungvari; Valéria Kecskeméti; Susanna Furst
Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants.
Current medicinal chemistry 1998;5(5):381-90.
1990: Susanna Furst
Brain monoamines are involved in the sedative effects of opiates and neuroleptics.
Progress in clinical and biological research 1990;328():311-4.
1988: Susanna Furst; Klára Gyires; Joseph Knoll
Analgesic profile of rimazolium as compared to different classes of pain killers.
Arzneimittel-Forschung 1988;38(4):552-7.
1986: Susanna Furst; T Friedmann; A Kovacs; T Wagner
Comparison of the opioid activity of CAM and kappa agonists.
NIDA research monograph 1986;75():224-7.